πŸ‡ΊπŸ‡Έ FDA
Patent

US 9540427

Peptide-based stat inhibitor

granted A61KA61K38/04A61K38/1709

Quick answer

US patent 9540427 (Peptide-based stat inhibitor) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/04, A61K38/1709, A61P, A61P35/00